Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, https://esmeeltvm989536.blogzet.com/tirzepatide-a-promising-new-treatment-for-obesity-51036038